McMurray v. De Vink

27 F. App'x 88
CourtCourt of Appeals for the Third Circuit
DecidedJanuary 4, 2002
Docket01-1346
StatusUnknown
Cited by4 cases

This text of 27 F. App'x 88 (McMurray v. De Vink) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McMurray v. De Vink, 27 F. App'x 88 (3d Cir. 2002).

Opinion

MEMORANDUM OPINION

McKEE, Circuit Judge.

Appellants Russell McMurray, Jr. and Elliot Walsey appeal an order by the District Court for the District of New Jersey staying this diversity action in favor of concurrent litigation that is proceeding in state court in Delaware. Appellants rely upon Colorado River Water Conserv. Dist. v. United States, 424 U.S. 800, 96 S.Ct. 1236, 47 L.Ed.2d 483 (1976) and its progeny in arguing that the district court abused its discretion by entering the stay. For the reasons that follow, we will reverse.

I. Facts

These consolidated actions arise from an aborted takeover battle between Appellees Warner-Lambert Company (“Warner”), and American Home Products Corporation (“AHP”). Warner is a Delaware corporation, with its principal place of business in New Jersey. It manufactures and sells pharmaceuticals world-wide. AHP also manufactures pharmaceutical products, and is also a Delaware corporation with its principal place of business in New Jersey.

On November 4, 1999, Warner announced an agreement to merge with AHP. The merger was valued at approximately $70 billion. The merger agreement valued each share of Warner stock at $83.55. The combined company was to have 20 directors, with ten coming from Warner and ten from AHP. Warner’s CEO was to be CEO of the combined company. AHP’s CEO was to be Chairman for 18 months, and was then to step aside in favor of Warner’s CEO. The merger agreement also contained a liquidated damage clause or “break-up fee” that required Warner to pay AHP $2 billion if Warner terminated the agreement.

The same day the Wamer/AHP merger was announced, Pfizer, Inc. another major manufacturer of pharmaceutical products, disclosed a bid for an “unfriendly” takeover of Warner. Pfizer’s offer to Warner was for $82.4 billion, and valued Warner stock at $96.40 per share, or $17.85 more per share than AHP’s offer. Pfizer’s offer was therefore more favorable to Warner shareholders. Unlike the AHP agreement, however, the Pfizer offer did not contain a provision for the Warner CEO or Warner directors to have a position in the company that would have been formed by the merger. The Warner/AHP merger *90 agreement lead to a flurry of lawsuits, including the one before us. Russell McMurray and Elliot Walsey (collectively, “the shareholders”) are shareholders of Warner. On November 10, 1999, McMur-ray filed a shareholder class action on behalf of Warner shareholders in the District Court for the District of New Jersey against Warner and AHP. Shortly thereafter, on November 23, 1999, Walsey filed a corporate derivative suit against Warner and AHP in the same court. The two complaints both arise from the merger agreement between Warner and AHP, contain the same facts and allegations, and rely exclusively upon Delaware law.

The shareholders’ complaint alleges that Warner directors initially refused to pursue serious merger discussions with Pfizer in violation of their fiduciary obligation to Warner’s shareholders. The alleged breach is based upon their reluctance to pursue Pfizer’s substantially higher offer. According to the averments, Pfizer attempted merger discussions with Warner on three previous occasions, but the Warner directors simply refused to entertain the possibility. The complaints also claim that Warner breached its fiduciary duty by agreeing to pay AHP the $2 billion breakup fee.

In addition to the federal suits, other Warner shareholders also began filing suits against Warner in state court in Delaware. To date, over 30 shareholder class action suits are pending in the Delaware courts as well as one derivative action. The Delaware suits were consolidated into Rosman v. De Vink, C.A. No. 17519-NC. The Delaware litigation is based upon the same allegations and requests the same relief as the Walsey and McMurray actions.

Warner and AHP filed motions asking the district court to abstain in favor of the litigation in Delaware state court, or in the alternative, to stay the proceedings while the Delaware litigation was pending. The district court refused to abstain, but issued an order “granting a stay and administratively terminating these cases.” McMurray and Walsey filed a motion for reconsideration, which the district court denied. This appeal followed.

II. Discussion

A. Jurisdiction

Preliminarily, Warner and AHP argue that the district court’s stay was not a final order under 28 U.S.C. § 1291, and that we therefore have no jurisdiction. However, that issue has already been resolved by the Supreme Court. In Moses H. Cone Memorial Hosp. v. Mercury Construction, Corp. 460 U.S. 1, 103 S.Ct. 927, 74 L.Ed.2d 765 (1983), the district court stayed federal litigation in favor of parallel proceedings in state court, and the propriety of that stay was challenged on appeal. In analyzing the jurisdictional issue, the Supreme Court concluded that “a stay of the federal suit pending resolution of the state suit meant that there would be no further litigation in the federal forum; the state court’s judgment on the issue would be res judicata.” 460 U.S. at 10, 103 S.Ct. 927. The Court held that the stay was therefore equivalent to a dismissal because the defendant was “effectively out of [federal] court.” Id. at 10, 13, 103 S.Ct. 927.

We have previously held that the pertinent jurisdictional inquiry under Moses H. Cone is whether the district court has surrendered its jurisdiction to the state court such that the stay will have res judicata effect in subsequent litigation in state court. See Spring City Corp. v. Am. Buildings Co., 193 F.3d 165, 171 (3d Cir. 1999). If it has that effect, the order staying the federal litigation is final and appealable. Id. Here, the issues raised in the Delaware litigation will be res judicata for purposes of the federal adjudication. *91 The defendants in the state and federal suits are the same, and plaintiffs Walsey and McMurray are represented in the Delaware shareholder action. Warner Br. at 6. Thus, a decision on the merits in state court will have a preclusive effect on the stayed federal case, putting the shareholders “effectively out of [federal] court.” See Moses H. Cone, 460 U.S. at 10, 103 S.Ct. 927. The stay is therefore a final order that is reviewable under § 1291.

B. The Stay

The shareholders contend that the district court applied the wrong legal standard in granting the stay. They insist that the abstention that resulted from the district court’s order is inconsistent with Colorado River and its progeny, and that the stay was, therefore, an abuse of discretion.

Colorado River involved the application of the McCarran Amendment, 43 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
27 F. App'x 88, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcmurray-v-de-vink-ca3-2002.